Versant Ventures raises $400 mln for sixth fund
Versant Ventures has closed its oversubscribed sixth healthcare-focused fund at a hard cap of $400 million. Fund VI will target between 20 and 25 biotech companies in the U.S., Canada and Europe. The firm is expected to deploy its initial investment from the fund in the first quarter of this year.
3 January 2017•3 mins read
